7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Applied Therapeutics Inc
(NASDAQ:APLT) 


Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headqu...

Founded: 2016
CEO: Shoshana Shendelman  
Sector: Health Technology
Industry: Biotechnology

Share this website to your friends
Applied Therapeutics Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0680.691,361.382,042.072,722.763,403.454,084.154,764.84
Applied Therapeutics Days Receivable Outstanding ttm (DSO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 01.492.974.465.957.448.9210.41
Applied Therapeutics Days Inventory Outstanding ttm (DIO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0561.561,123.111,684.672,246.222,807.783,369.343,930.89
Applied Therapeutics Op Cashflow Per Share ttm
202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.06-1.77-1.47-1.18-0.88-0.59-0.290
Applied Therapeutics Free Cashflow Per Share ttm
202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.06-1.77-1.47-1.18-0.88-0.59-0.290
Applied Therapeutics Cash Per Share ttm
202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.140.280.420.560.710.850.99
Applied Therapeutics P/S ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 08.7517.526.253543.7552.561.25
Applied Therapeutics (GAAP) P/E ratio ttm
202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -7.35-6.3-5.25-4.2-3.15-2.1-1.050
Applied Therapeutics P/B ratio ttm
202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -58.04-47.65-37.26-26.86-16.47-6.074.3214.72
No extra charts and metrics for this ticker.